CS-2570
|
|
|
- CAS号:
- 890129-26-7
- 英文名:
- BGG463
- 英文别名:
- K 0859;BGG463;K 03859;CS-2570;BGG 463;BGG-463;BGG463 (K03859);BGG463,K03859,inhibit,CDK,Cyclin dependent kinase,Inhibitor,K 03859,BGG-463,BGG 463,K-03859;6-((6-Acetamidopyrimidin-4-yl)oxy)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-1-naphthamide;6-(6-acetamidopyrimidin-4-yl)oxy-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]naphthalene-1-carboxamide;1-Naphthalenecarboxamide, 6-[[6-(acetylamino)-4-pyrimidinyl]oxy]-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-
- 中文名:
- CS-2570
- 中文别名:
- 化合物K 0859
- CBNumber:
- CB23067536
- 分子式:
- C30H29F3N6O3
- 分子量:
- 578.58
- MOL File:
- 890129-26-7.mol
|
|
|
CS-2570化学性质
-
沸点:
-
669.0±55.0 °C(Predicted)
-
|
-
密度:
-
1.366±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO : ≥ 125 mg/mL (216.05 mM)
-
|
-
酸度系数(pKa):
-
12.06±0.70(Predicted)
-
|
CS-2570性质、用途与生产工艺
BGG463 (K03859) 是一种具有口服活性的 II 型CDK2 的抑制剂。
BGG463 potently inhibits T315I BCR–ABL autophosphorylation and shows good oral efficacy in mouse models of CML.
CS-2570
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/01/25 | HY-100600 | BGG463 | | 1 mg | 571元 |
| 2024/01/25 | HY-100600 | CS-2570
BGG463 | 890129-26-7 | 5mg | 1500元 |
890129-26-7, CS-2570 相关搜索:
- 标准品
- C30H29F3N6O3
- 化合物K 0859
- 890129-26-7
- 6-((6-Acetamidopyrimidin-4-yl)oxy)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-1-naphthamide
- 1-Naphthalenecarboxamide, 6-[[6-(acetylamino)-4-pyrimidinyl]oxy]-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-
- BGG463,K03859,inhibit,CDK,Cyclin dependent kinase,Inhibitor,K 03859,BGG-463,BGG 463,K-03859
- 6-(6-acetamidopyrimidin-4-yl)oxy-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]naphthalene-1-carboxamide
- K 0859
- CS-2570
- BGG 463;BGG-463
- BGG463 (K03859)
- K 03859
- BGG463